Uveal Melanoma Cell Under Oxidative Stress - Influence of VEGF and VEGF-Inhibitors

Dithmer, M, Kirsch, AM, Graefenstein, L, Wang, F, Schmidt, H, Coupland, SE ORCID: 0000-0002-1464-2069, Fuchs, S, Roider, J and Klettner, AK (2019) Uveal Melanoma Cell Under Oxidative Stress - Influence of VEGF and VEGF-Inhibitors. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 236 (3). pp. 295-307.

Text Klin Monatsbl_1704_um_oxidative stress.pdf - Published version Download (688kB)

Abstract

<h4>Background</h4>The role of oxidative stress in cancer is complex. While the pathological alterations induced by oxidative stress may be involved in the induction of tumours, in the late stages of tumour development, it can facilitate the loss of tumour cells and might even prevent metastasis. Tumour cells show metabolic alterations, often inducing an increased production of reactive oxygen species, which makes these cells particularly vulnerable to additional oxidative stress. This is an important mode of action in the use of many chemotherapeutics and in the application of ionizing radiation. Uveal melanoma is the most frequent primary tumour in the adult eye. For metastasis of this tumour, which affects about 50 % of the patients, no appropriate treatment is currently available. However, the primary tumour can efficiently be treated with ionizing radiation. A frequent side effect of this treatment is radiation retinopathy, which is treated with vascular endothelial growth factor (VEGF) antagonists. A therapy of the primary tumour with VEGF antagonists is under discussion. So far, little data is available on this subject, however, a paradoxical worsening of the situation has been found in a mouse model of uveal melanoma treated with bevacizumab.<h4>Methods</h4>We have investigated the effect of VEGF and of the VEGF-antagonist bevacizumab on the survival of five different melanoma cell lines under oxidative stress treatment with hydrogen peroxide. In addition, we investigated the expression of relevant proteins and the effect of bevacizumab on the proliferation of the cells as well as its effect on the angiogenic behaviour of endothelial cells, co-cultured with uveal melanoma cells.<h4>Results</h4>Our study showed that not only VEGF but also, paradoxically, the VEGF-antagonist bevacizumab is able to protect uveal melanoma cells from oxidative stress-induced cell death. Bevacizumab did not influence the proliferation of the cells and showed only limited effectiveness to reduce angiogenic structures.<h4>Conclusion</h4>Considering that oxidative stress is the mode of action for ionizing radiation to induce cell death, a protective effect of bevacizumab on uveal melanoma cells against oxidative stress is worrisome and argues against the use of VEGF in uveal melanoma.

Item Type:	Article
Uncontrolled Keywords:	uveal melanoma, VEGF, oxidative stress, bevacizumab
Depositing User:	Symplectic Admin
Date Deposited:	09 Jun 2017 11:29
Last Modified:	19 Jan 2023 07:03
DOI:	10.1055/s-0043-103002
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3007893